These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12749724)

  • 1. Patterns of postmenopausal progestin use with estrogen in relation to endometrial cancer (United States).
    Newcomb PA; Trentham-Dietz A
    Cancer Causes Control; 2003 Mar; 14(2):195-201. PubMed ID: 12749724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women.
    Lacey JV; Brinton LA; Lubin JH; Sherman ME; Schatzkin A; Schairer C
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1724-31. PubMed ID: 16030108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen-progestin replacement therapy and endometrial cancer.
    Pike MC; Peters RK; Cozen W; Probst-Hensch NM; Felix JC; Wan PC; Mack TM
    J Natl Cancer Inst; 1997 Aug; 89(15):1110-6. PubMed ID: 9262248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of endometrial cancer following estrogen replacement with and without progestins.
    Weiderpass E; Adami HO; Baron JA; Magnusson C; Bergström R; Lindgren A; Correia N; Persson I
    J Natl Cancer Inst; 1999 Jul; 91(13):1131-7. PubMed ID: 10393721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of the duration of progestin use on the occurrence of endometrial cancer in postmenopausal women.
    Archer DF
    Menopause; 2001; 8(4):245-51. PubMed ID: 11449081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1996 Feb; 275(5):370-5. PubMed ID: 8569016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term use of postmenopausal estrogen and progestin hormone therapies and the risk of endometrial cancer.
    Doherty JA; Cushing-Haugen KL; Saltzman BS; Voigt LF; Hill DA; Beresford SA; Chen C; Weiss NS
    Am J Obstet Gynecol; 2007 Aug; 197(2):139.e1-7. PubMed ID: 17689625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postmenopausal estrogen and progestin use in relation to breast cancer risk.
    Newcomb PA; Titus-Ernstoff L; Egan KM; Trentham-Dietz A; Baron JA; Storer BE; Willett WC; Stampfer MJ
    Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):593-600. PubMed ID: 12101105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial cancer risk in estrogen users after switching to estrogen-progestin therapy.
    Chubak J; Doherty JA; Cushing-Haugen KL; Voigt LF; Saltzman BS; Hill DA; Beresford SA; Weiss NS
    Cancer Causes Control; 2007 Nov; 18(9):1001-7. PubMed ID: 17653829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial cancer and menopausal hormone therapy in the National Institutes of Health-AARP Diet and Health Study cohort.
    Lacey JV; Leitzmann MF; Chang SC; Mouw T; Hollenbeck AR; Schatzkin A; Brinton LA
    Cancer; 2007 Apr; 109(7):1303-11. PubMed ID: 17315161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
    Colditz GA; Hankinson SE; Hunter DJ; Willett WC; Manson JE; Stampfer MJ; Hennekens C; Rosner B; Speizer FE
    N Engl J Med; 1995 Jun; 332(24):1589-93. PubMed ID: 7753136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk?
    Trabert B; Wentzensen N; Yang HP; Sherman ME; Hollenbeck AR; Park Y; Brinton LA
    Int J Cancer; 2013 Jan; 132(2):417-26. PubMed ID: 22553145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose of progestin in postmenopausal-combined hormone therapy and risk of endometrial cancer.
    Reed SD; Voigt LF; Beresford SA; Hill DA; Doherty JA; Weiss NS
    Am J Obstet Gynecol; 2004 Oct; 191(4):1146-51. PubMed ID: 15507934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmenopausal hormone replacement therapy use and risk of endometrial cancer in Japanese women.
    Mizunuma H; Honjo H; Aso T; Urabe M; Ohta H; Kobayashi S; Sagara Y; Sanada M; Tanaka K; Dobashi K; Hayashi K; Ohama K
    Climacteric; 2001 Dec; 4(4):293-8. PubMed ID: 11770185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women.
    Stanford JL; Weiss NS; Voigt LF; Daling JR; Habel LA; Rossing MA
    JAMA; 1995 Jul; 274(2):137-42. PubMed ID: 7596001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women.
    Beresford SA; Weiss NS; Voigt LF; McKnight B
    Lancet; 1997 Feb; 349(9050):458-61. PubMed ID: 9040575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case-control study of postmenopausal hormone replacement therapy and endometrial cancer.
    Strom BL; Schinnar R; Weber AL; Bunin G; Berlin JA; Baumgarten M; DeMichele A; Rubin SC; Berlin M; Troxel AB; Rebbeck TR
    Am J Epidemiol; 2006 Oct; 164(8):775-86. PubMed ID: 16997897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy and endometrial, ovarian and colorectal cancer.
    Gambacciani M; Monteleone P; Sacco A; Genazzani AR
    Best Pract Res Clin Endocrinol Metab; 2003 Mar; 17(1):139-47. PubMed ID: 12763517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement therapy and the risk of endometrial cancer: A systematic review.
    Sjögren LL; Mørch LS; Løkkegaard E
    Maturitas; 2016 Sep; 91():25-35. PubMed ID: 27451318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of endometrial cancer following cessation of menopausal hormone use (Washington, United States).
    Green PK; Weiss NS; McKnight B; Voigt LF; Beresford SA
    Cancer Causes Control; 1996 Nov; 7(6):575-80. PubMed ID: 8932917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.